Vedanta’s four demerged entities debuted on exchanges, with brokerages highlighting aluminium as the most attractive segment. Analysts cite...

Brokerages remain selective on India's energy sector, favouring companies with strong growth drivers and attractive valuations. Morgan Stan...

Hong Kong-based CLSA will be rebranded under Citic Securities from 2027, ending a brokerage brand known for its distinctive culture and str...

Logistics firm A-1 Ltd has secured new orders totaling Rs 35 crore from prominent industrial houses, including Solar Industries Ltd, Mahadh...

Uday Kotak described SpaceX’s blockbuster IPO as a test for capitalism, questioning whether investors are backing humanity’s future or fuel...

India's new generation of Free Trade Agreements can act as a catalyst for manufacturing expansion, private capex revival and supply-chain i...

New RBI measures aim to make overseas borrowing cheaper for banks. External commercial borrowing costs may drop by up to 2.50 percent. This...

Banks are aggressively increasing interest rates on NRI dollar deposits. This move follows a special RBI dispensation to boost foreign curr...

Bank stocks saw a significant jump on Friday, propelling the Nifty Bank index to a one-month peak. This surge followed news of a potential ...

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...

ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Eyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...

Abu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

Brokerages remain selective on Indian equities, with Morgan Stanley maintaining an underweight stance on Wipro due to growth concerns. HDFC...

Indian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...